Advertisement

Topics

BRIEF-Biomarin Pharmaceutical provided update on mod-stage study of vosoritide

13:34 EDT 19 Oct 2016 | Reuters

* Biomarin Pharmaceutical - Provided update on phase 2 study of vosoritide, analog of C-type Natriuretic Peptide (CNP), in children with achondroplasia

Original Article: BRIEF-Biomarin Pharmaceutical provided update on mod-stage study of vosoritide

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Biomarin Pharmaceutical provided update on mod-stage study of vosoritide"

Quick Search
Advertisement
 

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...